Brought to you by 
Biotronik, Conor Medsystems sign two drug-eluting stent deals
21 Jul 2004
Executive Summary
Medical device company Biotronik GMBH & Co. (cardiac electrotherapy and vascular intervention), through its Swiss affiliate, has signed two agreements with Conor Medsystems (developing stents to treat vascular disease). Both deals involve drug-eluting stents.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Site Specific
-
Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com